The EpiSignal RTG funded by the Deutsche Forschungsgemeinschaft (DFG) studies the crosstalk of intracellular signaling pathways and chromatin modification networks. EpiSignal aims to increase the molecular understanding of how the complex networks of cell and epigenome signaling systems determine cell responses and phenotypes, during normal cell development and differentiation, but also in the progression of diseases such as cancer.
The EpiSignal faculty comprises nine groups from the University of Stuttgart and one from the University of Tübingen. The team combines strong, internationally recognized expertise in the fields of biochemistry, cell biology, molecular (epi)genetics and systems biology. All principal investigators are highly qualified leaders and experts in cutting-edge technologies, with strong publication records in their fields, and experienced in the supervision and mentoring of doctoral researchers.
Considering the growing demand for experts in this exciting field of biomedical research, EpiSignal offers a state-of-the-art interdisciplinary training program at the intersection of cell signaling and molecular epigenetics, that optimally prepares doctoral researchers for future career paths in academia or industry. The EpiSignal qualification program includes interdisciplinary lecture series and workshops, regular scientific seminars with progress and paper presentations, annual retreats with international visiting scientists, tech schools with peer-to-peer training in advanced methods, training in transferable skills, lab visits abroad, industrial internships and conference participation.